MLYS
Mineralys Therapeutics Inc

520
Mkt Cap
$2.86B
Volume
1.56M
52W High
$47.65
52W Low
$8.24
PE Ratio
-12.19
MLYS Fundamentals
Price
$36.05
Prev Close
$36.20
Open
$36.04
50D MA
$40.98
Beta
0.00
Avg. Volume
1.9M
EPS (Annual)
-$3.66
P/B
4.94
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
73,921 Shares in Mineralys Therapeutics, Inc. $MLYS Acquired by Walleye Capital LLC
Walleye Capital LLC acquired a new stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
22NW LP Purchases 98,698 Shares of Mineralys Therapeutics, Inc. $MLYS
22NW LP lifted its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·4d ago
News Placeholder
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven research firms that are covering the stock, MarketBeat Ratings...
MarketBeat·6d ago
News Placeholder
Wall Street Analysts Think Mineralys Therapeutics, Inc. (MLYS) Could Surge 27.55%: Read This Before Placing a Bet
The mean of analysts' price targets for Mineralys Therapeutics, Inc. (MLYS) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·7d ago
News Placeholder
Mineralys Therapeutics, Inc. $MLYS Shares Sold by Quadrature Capital Ltd
Quadrature Capital Ltd reduced its position in Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 83.6% in the 2nd quarter, according to its most recent filing with the Securities and...
MarketBeat·7d ago
News Placeholder
Virtus Investment Advisers LLC Sells 7,192 Shares of Mineralys Therapeutics, Inc. $MLYS
Virtus Investment Advisers LLC lessened its holdings in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 53.3% during the 2nd quarter, according to its most recent filing with...
MarketBeat·10d ago
News Placeholder
Prudential Financial Inc. Increases Stake in Mineralys Therapeutics, Inc. $MLYS
Prudential Financial Inc. raised its stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 176.5% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·10d ago
News Placeholder
ProShare Advisors LLC Takes $141,000 Position in Mineralys Therapeutics, Inc. $MLYS
ProShare Advisors LLC purchased a new position in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·16d ago
News Placeholder
Brian Taylor Slingsby Sells 1,000,000 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Brian Taylor Slingsby sold 1,000,000 shares of Mineralys Therapeutics stock in a transaction that occurred on Thursday, November...
MarketBeat·19d ago
News Placeholder
Mineralys Therapeutics (NASDAQ:MLYS) Director Brian Taylor Slingsby Sells 1,000,000 Shares
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Brian Taylor Slingsby sold 1,000,000 shares of the business's stock in a transaction on Thursday, November 20th. The stock was...
MarketBeat·20d ago

Latest MLYS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.